Quarterly report pursuant to Section 13 or 15(d)

Operating Segments (Tables)

Operating Segments (Tables)

6 Months Ended

Jun. 30, 2022

Schedule of Segment Reporting Information

The table below presents certain financial information of our operating segments for the three and six months ended June 30, 2022 and 2021 (in thousands):

Segment Reporting for the Quarter Ended June 30, 2022

	Treatment			Services		Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	8,393		$	11,062	$	19,455		$	—		$	19,455
Intercompany revenues		—			17		17			—			—
Gross profit		1,563			1,321		2,884			—			2,884
Research and development		59			8		67			13			80
Interest income		—			—		—			29			29
Interest expense		(19	)		3		(16	)		(25	)		(41	)
Interest expense-financing fees		—			—		—			(15	)		(15	)
Depreciation and amortization		381			86		467			13			480
Segment income (loss) before income taxes		364			515		879			(1,789	)		(910	)
Income tax expense		304			43		347			—			347
Segment income (loss)		60			472		532			(1,789	)		(1,257	)
Expenditures for segment assets		373			39		412			—			412	⁽³⁾

Segment Reporting for the Six Months Ended June 30, 2022

	Treatment			Services			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	15,872		$	19,498		$	35,370		$	—		$	35,370
Intercompany revenues		—			27			27			—			—
Gross profit		2,201			2,319			4,520			—			4,520
Research and development		124			23			147			29			176
Interest income		—			—			—			40			40
Interest expense		(33	)		2			(31	)		(45	)		(76	)
Interest expense-financing fees		—			—			—			(28	)		(28	)
Depreciation and amortization		752			157			909			27			936
Segment (loss) income before income taxes		(117	)		799			682			(3,514	)		(2,832	)
Income tax benefit		(254	)		(72	)		(326	)		—			(326	)
Segment income (loss)		137			871			1,008			(3,514	)		(2,506	)
Expenditures for segment assets		670			88			758			—			758	⁽³⁾

Segment Reporting for the Quarter Ended June 30, 2021

	Treatment			Services			Medical			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	7,706		$	8,439			—		$	16,145		$	—		$	16,145
Intercompany revenues		319			32			—			351			—			—
Gross profit (negative gross profit)		1,433			(467	)		—			966			—			966
Research and development		43			19			72			134			10			144
Interest income		—			—			—			—			2			2
Interest expense		(18	)		—			—			(18	)		(47	)		(65	)
Interest expense-financing fees		—			—			—			—			(9	)		(9	)
Depreciation and amortization		310			85			—			395			5			400
Segment income (loss) before income taxes		471			(1,292	)		(72	)		(893	)		4,027	⁽²⁾		3,134
Income tax expense		3			10			—			13			—			13
Segment income (loss)		468			(1,302	)		(72	)		(906	)		4,027			3,121
Expenditures for segment assets		270			10			—			280			9			289	⁽⁴⁾

Segment Reporting for the Six Months Ended June 30, 2021

	Treatment			Services			Medical			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	15,201		$	24,077			—		$	39,278		$	—		$	39,278
Intercompany revenues		979			39			—			1,018			—			—
Gross profit		2,358			964			—			3,322			—			3,322
Research and development		90			32			149			271			24			295
Interest income		—			—			—			—			21			21
Interest expense		(37	)		(8	)		—			(45	)		(87	)		(132	)
Interest expense-financing fees		—			—			—			—			(17	)		(17	)
Depreciation and amortization		620			170			—			790			9			799
Segment income (loss) before income taxes		352			(737	)		(149	)		(534	)		2,613	⁽²⁾		2,079
Income tax (benefit) expense		(14	)		10			—			(4	)		—			(4	)
Segment income (loss)		366			(747	)		(149	)		(530	)		2,613			2,083
Expenditures for segment assets		627			14			—			641			9			650	⁽⁴⁾

⁽¹⁾

Amounts reflect the activity for corporate headquarters not included in the segment information.

⁽²⁾

Amounts includes approximately $5,381,000 of “Gain on extinguishment of debt” recorded in connection with the Company’s PPP Loan which was forgiven by the U.S Small Business Administration effective June 15, 2021.

⁽³⁾

Net of financed amount of $0 and $114,000 for the three and six months ended June 30, 2022, respectively.

⁽⁴⁾

Net of financed amount of $0 and $29,000 for the three and six months ended June 30, 2021, respectively.